Imbruvica (ibrutinib) - AbbVie, J&J
Venclexta (venetoclax) - Roche, AbbVie
docirbrutinib (AS-1763) - Carna Biosci
Jaypirca (pirtobrutinib) - Eli Lilly
AZD5991 - AstraZeneca
https://ash.confex.com/ash/2024/webprogram/Paper210788.html
 
Natalia Timofeeva, MD1; Breana Herrera1; Shady I. Tantawy, MD1; Hitomi Fujiwara, PhD2; Lizbeth Loza1; Mariko Hatakeyama2; Tokiko Asami2; Hiroshi Ohmoto2; Kyoko Miyamoto3; Yu Nishioka2; Akinori Arimura3; Masaaki Sawa, PhD2; Nitin Jain, MD4; Varsha Gandhi, PhD1,4
 
Nov 6, 2024
 
Prev Next